Search

Your search keyword '"Philippe Clezardin"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Philippe Clezardin" Remove constraint Author: "Philippe Clezardin"
22 results on '"Philippe Clezardin"'

Search Results

1. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.

2. Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer

3. Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay

4. Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis

5. How Do Bisphosphonates Inhibit Bone Metastasis In Vivo

6. Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.

7. Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CT

8. Expression of neuronal Na+ leak channel, NALCN, provides for persistent invasion of metastasizing cancer cells

9. LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer

10. Mechanical strength prediction of tumoral bones using numerical simulation

12. Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases

13. Non-coding RNA in rhabdomyosarcoma progression and metastasis

14. List of Contributors

15. The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases

17. The role of osteoclasts in breast cancer bone metastasis

18. Cell Membrane Proteomic Analysis Identifies Proteins Differentially Expressed in Osteotropic Human Breast Cancer Cells

19. Numerical Simulation of Metastatic Bone Strength

20. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

21. A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.

Catalog

Books, media, physical & digital resources